Benefits
Sleep Quality and Stress
Magnesium glycinate is widely used for sleep and anxiety — combining magnesium's NMDA receptor antagonism and GABA modulation with glycine's independent inhibitory neurotransmitter effects. Glycine supplementation alone (3 g) has been shown to improve sleep quality; the chelate provides both.
Superior GI Tolerability
Unlike magnesium citrate or oxide (which cause loose stools/diarrhea via osmotic effect), magnesium glycinate is gentle on the GI tract. Allows higher cumulative dosing without bowel disruption — particularly valuable for those needing to correct deficiency.
Muscle Cramps and Recovery
Magnesium is critical for neuromuscular function and ATP production. Glycinate form provides bioavailable magnesium without GI distress that could disrupt training/recovery routines.
Anxiety Reduction
Some evidence suggests magnesium supplementation modestly reduces anxiety symptoms — particularly in deficient populations. Boyle 2017 systematic review showed potential benefit; effect sizes modest.
Migraine Prevention (Adjunct)
Magnesium (any form) is supported by AHS/AAN as Level B evidence for migraine prevention. Glycinate form preferred for chronic daily dosing due to GI tolerability.
Mechanism of action
Glycine Chelate Stability
Bisglycinate structure protects magnesium from gastric pH changes and competing absorption inhibitors (phytates, oxalates, calcium). Chelation is thought to allow absorption via dipeptide transporters in addition to standard mineral transport pathways.
NMDA Receptor Antagonism
Magnesium gates NMDA glutamate receptors — provides inhibitory tone in the CNS. May contribute to anxiolytic and sleep-promoting effects.
Glycine Inhibitory Neurotransmission
Glycine itself is an inhibitory CNS neurotransmitter (acts on glycine receptors and as NMDA co-agonist at glycine site). Provides additive calming effects beyond magnesium alone.
Reduced Osmotic GI Effect
Unlike highly water-soluble magnesium salts (citrate, oxide), the chelate does not pull water osmotically into the bowel — eliminating the laxative effect that limits other forms.
Clinical trials
Randomized crossover trial comparing oral magnesium bisglycinate vs magnesium oxide vs placebo in healthy adults. Outcomes: serum magnesium, red blood cell magnesium, urinary excretion. (Multiple PK trials)
Healthy adults.
Magnesium bisglycinate produced higher serum/RBC magnesium AUC vs oxide. Better GI tolerability (less laxative effect). Industry-funded research dominates this space. Note: 2024 Natural Calm trial (NCT03353636) compared magnesium carbonate vs bisglycinate vs citrate — manufacturer-sponsored.
Systematic review of 18 studies examining magnesium supplementation effects on subjective anxiety. Various magnesium forms included.
Pooled across anxiety RCTs.
Magnesium modestly reduced anxiety symptoms vs placebo, particularly in anxious populations. Effect sizes modest. CRITICAL CAVEAT: study quality variable; not specific to glycinate form. Standard anxiety care (SSRIs, CBT) remains foundational.
About this ingredient
Magnesium glycinate (also called magnesium bisglycinate) is a CHELATE — magnesium ion bonded with two glycine amino acid molecules. Distinguished from inorganic magnesium salts by superior GI tolerability and bioavailability. Elemental magnesium content: ~14% by weight (so 1,000 mg magnesium glycinate provides ~140 mg elemental magnesium). Compare to magnesium oxide (~60% elemental Mg but poorly absorbed) and citrate (~16%). Typical dose: 200-400 mg elemental magnesium/day (which translates to ~1,400-2,800 mg of the chelate).
EVIDENCE-BASED USES: (1) Magnesium repletion without GI distress (the dominant clinical advantage); (2) Sleep — glycine independently improves sleep quality; combined with magnesium for additive effects; (3) Anxiety/stress — modest evidence; (4) Muscle cramps; (5) Migraine prevention adjunct (AHS/AAN Level B for magnesium generally).
CRITICAL CAUTIONS: (1) RENAL IMPAIRMENT — kidneys excrete magnesium; CKD patients can develop hypermagnesemia; consult nephrologist; (2) HEART BLOCK — high-dose IV magnesium contraindicated; oral very rarely; (3) DRUG INTERACTIONS — bisphosphonates, tetracycline/quinolone antibiotics, levothyroxine all reduced by magnesium chelation; separate by 2-4 hours; (4) DOSE — UL is 350 mg/day from supplemental sources (food magnesium not counted); higher doses cause diarrhea (less so with glycinate) but total intake should consider RDA + supplemental + food; (5) Pregnancy/lactation safe at typical doses; (6) DRUG ABSORPTION — magnesium is a cation that chelates many drugs in the gut — always check interactions for chronic medications.